Protagonist Therapeutics (PTGX US)

Analysis

Health Care • United States

Protagonist Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Protagonist Therapeutics serves customers worldwide.

Refresh

Company Event • 21 Feb 2026 01:30 • Upcoming

Add To Calendar

Q4 2025

Company Event • 07 Nov 2025 04:00 • Upcoming

Add To Calendar

Q3 2025

Company Event • 07 Aug 2025 04:00 • Upcoming

Add To Calendar

Q2 2025

Company Event • 01 Jul 2025 04:30 • Latest

Status Update

Company Event • 05 Jun 2025 01:25

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q4 2025

Q3 2025

Q2 2025

Status Update

Jefferies Global Healthcare Conference 2025